The company faces risks from global economic uncertainty, international conflicts, currency fluctuations, interest rate increases, and acquisition integration challenges. Manufacturing and distribution disruptions, cybersecurity threats, competitive pricing pressure, and regulatory changes (including FDA and foreign regulations) are also significant concerns. Debt covenants and potential tax liabilities add further risk. The company also faces risks related to market acceptance of new products and services.
Financial Upside
The company is optimistic about the long-term prospects of the contact lens and healthcare markets. Growth opportunities exist in contact lenses, particularly myopia management, and in CooperSurgical's fertility and women's health segments. Recent acquisitions, like Cook Medical, and the 2024 revolving credit facility, are expected to contribute to future growth. The company anticipates increased sales and operating income, though foreign exchange fluctuations may partially offset gains.
